Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutrastar Names New Chief Financial Officer
Most recently, Mr Tick has served as chief financial officer and corporate secretary for ANDA Networks, a telecom networking equipment supplier operating in North America and China. Mr
Most recently, Mr Tick has served as chief financial officer and corporate secretary for ANDA Networks, a telecom networking equipment supplier operating in North America and China. Mr
Venus Remedies said that in the seven accredited facilities the company produces drugs for oncology lyophilized, cardiovascular, oncology liquid, carbapenem, small volume infusion and other speciality injection. Venus
Trial By Fire Solutions said that SimpleCTMS was developed as Software as a Service (SaaS) and it provides biotechnology, pharmaceutical, and medical device companies a flexible, intuitive, comprehensive
Lampion Pack is a single pack containing Lansoprazole (Japanese brand name: Takepron capsules 30), amoxicillin hydrate (Japanese brand name: Amolin capsules 250) and Metronidazole. Takeda said that a
Maxygen and Cangene have entered into an agreement in May 2009, under which Maxygen received from Cangene a non-refundable option fee of $500,000. As per the terms of
Stiefel said that the combination of a topical retinoid and an antibiotic are often recommended for the treatment of acne vulgaris. Veltin gel brings these two drug classes
Wyeth and Nycomed’s request for FDA to reset the date of Teva’s final approval to January 2011, based on the fact that Teva has patent defenses remaining at
Cytosol develops anticoagulants and other products to aid in the processing of blood components. The company has three proprietary products with new drug application approvals: TriCitrasol, noClot-50 and
Emisphere Technologies’ EligenTechnology can be applied to the oral route of administration as well as other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. Emisphere Technologies
Sanofi-aventis said that Jevtana, an intravenously administered microtubule inhibitor, is approved in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated